Richard Sullivan is Professor of Cancer & Global Health at Kings College London (KCL), Director, Institute of Cancer Policy and Co-Director of King’s Conflict & Health Research Group. Richard serves on the executive boards of King’s Health Partners Comprehensive Cancer Centre, the Kings’ Centre for Global Health and the Union for International Cancer Control. He also holds Visiting Chairpersons at the Universidad Catolica, Santiago and Tata Memorial Centre, Mumbai and is an elected Fellow of the European Academy of Cancer Sciences. Richard is past UK Director of the Council for Emerging National Security Affairs (CENSA) a national security think-tank where he specialised in counter-proliferation and the security implications of global health. Richard qualified in medicine, and trained in surgery (urology) gaining his PhD in cell signalling from University College London. He was clinical director of Cancer Research UK between 1999 and 2008. Following a period at the London School of Economics working on complex healthcare systems he moved to King’s College London in 2011. Richard’s research programmes focus on global cancer policy and conflict & health. In cancer public policy he has worked on a range of global policy research programmes, most recently Lancet Commission on Global Surgery 2030, Lancet Series on Women’s Equity, Health and Cancer and the Lancet Oncology Commission on Global Cancer Surgery. The King’s Conflict & Research Group is also carrying out a Lancet Commission into Civil-Military co-operation in Global Health, in addition to a wide variety of field studies including: basic package of health services in Afghanistan, armed violence reduction as public health measure, intelligence, security and global health, and health intelligence in the Syrian conflict. Richard has worked extensively in many conflict regions from the Balkans through to Afghanistan, Libya, Syria and DR Congo in both healthcare systems reconstruction and cancer control. In global ageing the Institute of Cancer Policy is working on the demographic impact of ageing middle income countries such as Mexico on cancer care and research systems, as well as cancer surgical issues germane to ageing population. The Conflict and Health Group is also involved in a study of the elderly refugee population and cancer care models.